C12N 2710/16644
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/16644 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 4 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 21
- Assignees
- 10
- Inventors
- 37
- Latest grant
- 1 Mar 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 1 | 4 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating diseases1 Mar 2022US 11,261,460 B2University of Florida Research Foundation, Inc.
- AAV production using suspension adapted cells28 Dec 2021US 11,208,630 B2University of Florida Research Foundation, Inc.
- Compositions and methods for treating diseases9 Feb 2021US 10,912,804 B2University of Florida Research Foundation, Inc.
- HSV/AAV hybrid amplicon vectors12 Oct 1999US 5,965,441 AThe General Hospital Corporation
- Adeno-Associated Virus Production Platform9 Jul 2026US 2026/0193676 A1MedImmune, LLC
- Methods and compositions for the production of recombinant adeno-associated virus (raav) vectors25 Sep 2025US 2025/0297286 A1Beacon Therapeutics (USA), Inc.
- Improved aav production using potassium chloride21 Dec 2023US 2023/0407329 A1University of Florida Research Foundation, Inc.
- Dual viruses and dual oncolytic viruses and methods of treatment1 Dec 2022US 2022/0380735 A1Oncorus, Inc.
- Recombinant herpesvirales vector29 Sep 2022US 2022/0307052 A1Solid Biosciences Inc.
Most cited
By later US patents
- Compositions and methods for treating diseases6US 10,912,804 B2University of Florida Research Foundation, Inc. · 2021
- HSV/AAV hybrid amplicon vectors5US 5,965,441 AThe General Hospital Corporation · 1999
- Compositions and methods for treating diseases3US 11,261,460 B2University of Florida Research Foundation, Inc. · 2022
- AAV production using suspension adapted cells1US 11,208,630 B2University of Florida Research Foundation, Inc. · 2021